News

NORD Holding backs German animal-health firm alfavet for European push

What's the deal? A fund advised by NORD HoldingDealroom has a profile for this one. Try Dealroom → has taken a stake in alfavet, a Neumünster-based maker of veterinary medicines and nutraceuticals, in a growth partnership announced in November 2026. The German private equity firm aims to build alfavet into a leading European animal-health platform. Existing shareholders are reinvesting; the deal value and stake were not disclosed.

What does alfavet do? Founded in 2003, the company supplies veterinary practices with medicines, nutraceuticals, and care products across areas including the gastrointestinal tract, kidneys and urinary system, and cardiovascular health. It runs its own production in Neumünster and also operates as a contract development and manufacturing organisation (CDMO) for third parties.

What's the endgame? NORD Holding and alfavet plan to grow through expansion into selected European markets and targeted acquisitions to widen the product range. Konstantin Wree, who became chief executive officer in early 2025 and is also a shareholder, will continue to lead the business.

Why now? alfavet frames the animal-health market as structurally growing, driven by the humanisation of pets, their longer lifespans and related age-related conditions, and wider acceptance of supplements among vets.

"With NORD Holding we have found a partner who shares our growth plans and gives us the means to implement them both organically and through targeted acquisitions," Wree said (translated from German).

Who's backing it? NORD Holding, with more than 50 years of history and €5.0 billion in assets under management, ranks among Germany's leading private equity and asset management firms. It is currently invested in 16 companies in Germany and German-speaking Europe, focusing on succession financing, carve-outs, and expansion capital for mid-sized businesses.

The signal: The deal fits a wider pattern of private-equity-backed consolidation in animal health, alongside moves such as CharterhouseDealroom has a profile for this one. Try Dealroom →'s 2026 acquisition of UK-based AnimalcareDealroom has a profile for this one. Try Dealroom → and NORD-backed OR Technology's combination with Hallmarq Veterinary ImagingDealroom has a profile for this one. Try Dealroom →. Its significance will hinge on execution, since no transaction value or specific expansion targets were disclosed.

Read more: majunke.com

Image credit: "140602-N-IL267-110" by SurfaceWarriors, licensed under CC BY-SA 2.0

More top stories